R. Komaki

Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410

Walter J. Curran, Rebecca Paulus, Corey J. Langer et al. · JNCI Journal of the National Cancer Institute · 2011 · 1.2K citations · Full text

Medicine, Oncology, Radiation Oncology +13

A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): A report of the 2 year and median survival (MS) for the RTOG 0324 trial

G. R. Blumenschein, Rebecca Paulus, Walter J. Curran et al. · Journal of Clinical Oncology · 2008 · 35 citations

Medicine, Oncology, Pharmacology +17

Phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small cell lung cancer.

R. Komaki, G. R. Blumenschein, Ignacio I. Wistuba et al. · Journal of Clinical Oncology · 2011 · 17 citations

Medicine, Oncology, Radiation Oncology +16

16 Intratumoral microvascular density using factor 8 and CDK31 correlates with outcome for squamous cell carcinoma but not adenocarcinoma of the lung

R. Komaki, Johnson Ro, Peter Allen et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 10 citations

Medicine, Oncology, Pathology +16